Literature DB >> 22965611

Reduction of vascular endothelial growth factor a in human breast milk after intravitreal injection of bevacizumab but not ranibizumab.

Christoph Ehlken1, Gottfried Martin, Andreas Stahl, Hansjürgen Thomas Agostini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22965611     DOI： 10.1001/archophthalmol.2012.112

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  3 in total

1.  [Anti-VEGF (anti-vascular endothelial growth factor) treatment for central vein occlusion during breastfeeding].

Authors:  S Groselli; L Bechstein; K Gabka; M Ulbig
Journal:  Ophthalmologie       Date:  2022-07-20

2.  Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report.

Authors:  Ying Huang; Rong Zhou; Zuhua Sun; Yihan Zheng; Bing Lin
Journal:  Int Breastfeed J       Date:  2022-03-31       Impact factor: 3.461

3.  Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology.

Authors:  Noura Al Qassimi; Igor Kozak; Maysoon Al Karam; Piergiorgio Neri; Patricio M Aduriz-Lorenzo; Alaa Attawan; Mohamed Awadalla; Ahmed El Khashab; Mohamed Abdul-Nabi; Ammar Safar; Hanan Al Shamsi; Prasan Rao; Madhav Rao; Amr Farid; Avinash Gurbaxani
Journal:  Ophthalmol Ther       Date:  2022-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.